Topics PMDA and JPMA Jointly Host COVID-19 Session at DIA China 2021
DIA China 2021" was held in Suzhou, China from May 20 to 23, 2021, and JPMA held a 90-minute "COVID-19 Session" in the morning of May 23 in collaboration with the Pharmaceuticals and Medical Devices Agency (PMDA).
Conference Logo
On the day of the conference, the Japanese side participated online and the Chinese side participated from the DIA venue in Suzhou, China, due to the difficulties in coming and going between Japan and China caused by the new coronavirus infection.
The meeting was co-chaired by Mr. Nobumasa Nakajima, Executive Officer of the Pharmaceuticals and Medical Devices Agency (PMDA), and Ms. Sachiko Nakagawa, Executive Director of the JPMA, and the meeting proceeded with a discussion on the Japanese pharmaceutical regulatory authority's measures against novel coronavirus infection (flexible timing of the start of clinical trials and priority review for novel coronavirus infection-related products, free consultation on vaccines and The presentation included introductions from both the regulatory authorities (Mr. Yuji Matsukura, Assistant Director, International Affairs Regulatory Affairs Office, MHLW, and Mr. Daisuke Koga, Director, International Affairs Division, PMDA) and industry (Mr. Hironobu Hiyoshi, Chairperson, JPMA Drug Evaluation Committee) on the measures being taken by the Japanese regulatory authorities against novel coronavirus infection (e.g., flexible timing of initiation of clinical trials for novel coronavirus-related products, priority review, publication of evaluation approach, and GCP/GMP inspection).
Scene of the session
The venue in Suzhou was attended by Kiyoshi Horie, Vice Chairperson of JPMA's International Affairs Committee, Hiroshi Nishiyama, China Team Leader, and about 50 people from China, including volunteers from the China Pharmaceuticals Subcommittee, The R&D-based Pharmaceutical Association Committee (RDPAC) of the China Association of Foreign Investment Companies also provided constructive comments and evaluations.
The venue
Finally, I would like to take this opportunity to thank everyone involved for their efforts in organizing the joint session at DIA China, which was the first attempt for JPMA to do so.
( Yumiko Kobayashi, Kota Suzuki, Hiroshi Nishiyama, and Kiyoshi Horie, China Team, Asia Committee, International Affairs Committee)